Hisham Turjman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hisham Turjman has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Alan David Kaye
Department of Anesthesiology, Louisiana State University Health Shreveport, Shreveport, LA 71103, USA
3 shared publications - Jeremiah Hilkiah Wijaya
School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
3 shared publications - Kevin Yabut
Louisiana State University Health Sciences Center, Shreveport, USA
3 shared publications - Muhammad Abubakar Ayub
Department of Neurology, Louisiana State University Health Sciences Center at Shreveport, Shreveport, USA
3 shared publications - Nihar Upadhyay
Department of Internal Medicine, GMERS Medical College, Gotri, Vadodara, India
3 shared publications - Saurabh Kataria
Louisiana State University Health Sciences Center at Shreveport
3 shared publications
Latest Publications
- Open Access
- 26 April 2026
- Published by Springer Nature in Cureus
- Vol. 18 (4)
Proximal Femoral Replacement for Infected Non-union of the Proximal Femur With Adherent Femoral Artery: Surgical Challenges and Techniques to Minimize Vascular Risk
Chronic infection and non-union of the proximal femur pose significant reconstruction challenges, where repeated surgical interventions can lead to bone loss and vascular adherence. The attachment of the profunda femoral artery (PFA) adds a substantial risk of intra-operative bleeding. We report a case of a 72-year-old female patient with ongoing pain and severe functional limitation after failed fixation complicated by chronic infection and subsequent excision arthroplasty. She underwent a proximal femur replacement (PFR) using a DePuy Synthes modular system with a constrained acetabular liner. Before the operation, infection control was achieved, and vascular mapping was done via CT angiogram, which suggested tethering of the PFA to the medial femoral cortex. Sharp dissection, vascular isolation with loops, and Doppler monitoring were all part of the intra-operative strategy used. This case report demonstrates that PFR can be an effective limb salvage option in the context of chronic infection and non-union of a proximal femoral fracture, and how operational success depends on careful pre-operative planning and precise surgical execution.
- 26 April 2026
- Published by Springer Nature in Cureus
- Vol. 18 (4)
Open AccessProximal Femoral Replacement for Infected Non-union of the Proximal Femur With Adherent Femoral Artery: Surgical Challenges and Techniques to Minimize Vascular Risk
Chronic infection and non-union of the proximal femur pose significant reconstruction challenges, where repeated surgical interventions can lead to bone loss and vascular adherence. The attachment of the profunda femoral artery (PFA) adds a substantial risk of intra-operative bleeding. We report a case of a 72-year-old female patient with ongoing pain and severe functional limitation after failed fixation complicated by chronic infection and subsequent excision arthroplasty. She underwent a proximal femur replacement (PFR) using a DePuy Synthes modular system with a constrained acetabular liner. Before the operation, infection control was achieved, and vascular mapping was done via CT angiogram, which suggested tethering of the PFA to the medial femoral cortex. Sharp dissection, vascular isolation with loops, and Doppler monitoring were all part of the intra-operative strategy used. This case report demonstrates that PFR can be an effective limb salvage option in the context of chronic infection and non-union of a proximal femoral fracture, and how operational success depends on careful pre-operative planning and precise surgical execution.
- 22 January 2025
- Published by Springer Nature in Current Pain and Headache Reports
- Vol. 29 (1) , 1-12
A Systematic Review and Meta-Analysis of Stem Cell Therapies for Pain in Diabetic Neuropathy, Osteoarthritis, and Spinal Cord Injuries
Purpose of Review The use of stem cell therapy is a rapidly evolving and progressing frontier of science that has been used to treat illnesses such as malignancies, immunodeficiencies, and metabolic syndromes. This review aims to give an overview of the use of stem cell therapy in the treatment of pain caused by diabetic neuropathy, osteoarthritis, and other spinal cord pathologies. Recent Findings Pain is defined as a generalized or localized feeling of distress related to a physical or emotional stimulus and can be caused by a multitude of pathologies. The field of pain management has explored many strategies such as gene therapies, neuromodulation, platelet-rich plasma, and numerous pharmacotherapies. The approach to the delivery of these strategies has varied, with the method of stem cell therapy delivery being the focus of this present investigation. In addition, we combined several different studies to analyze the effects of stem cell therapies and improvement in pain scores quantified by the visual analog scale (VAS). The overall results showed a mean difference of -2.58, suggesting that the stem cell treatment group had a lower VAS score at 6 months compared to the control group. Summary The use of different types of stem cells, such as pluripotent and mesenchymal stem cells, play a critical role in the care of cases suffering from pain. Effective delivery methods are evolving and can transform treatment options in the future, for which large cohort studies are warranted.
- 22 January 2025
- Published by Springer Nature in Current Pain and Headache Reports
- Vol. 29 (1) , 1-12
A Systematic Review and Meta-Analysis of Stem Cell Therapies for Pain in Diabetic Neuropathy, Osteoarthritis, and Spinal Cord Injuries
Purpose of Review The use of stem cell therapy is a rapidly evolving and progressing frontier of science that has been used to treat illnesses such as malignancies, immunodeficiencies, and metabolic syndromes. This review aims to give an overview of the use of stem cell therapy in the treatment of pain caused by diabetic neuropathy, osteoarthritis, and other spinal cord pathologies. Recent Findings Pain is defined as a generalized or localized feeling of distress related to a physical or emotional stimulus and can be caused by a multitude of pathologies. The field of pain management has explored many strategies such as gene therapies, neuromodulation, platelet-rich plasma, and numerous pharmacotherapies. The approach to the delivery of these strategies has varied, with the method of stem cell therapy delivery being the focus of this present investigation. In addition, we combined several different studies to analyze the effects of stem cell therapies and improvement in pain scores quantified by the visual analog scale (VAS). The overall results showed a mean difference of -2.58, suggesting that the stem cell treatment group had a lower VAS score at 6 months compared to the control group. Summary The use of different types of stem cells, such as pluripotent and mesenchymal stem cells, play a critical role in the care of cases suffering from pain. Effective delivery methods are evolving and can transform treatment options in the future, for which large cohort studies are warranted.
- Open Access
- 10 July 2024
- Published by Springer Nature in Current Pain and Headache Reports
- Vol. 28 (12) , 1387
Correction to: The Role of Platelet Rich Plasma in Vertebrogenic and Discogenic Pain: A Systematic Review and Meta-Analysis
- 10 July 2024
- Published by Springer Nature in Current Pain and Headache Reports
- Vol. 28 (12) , 1387
Open AccessCorrection to: The Role of Platelet Rich Plasma in Vertebrogenic and Discogenic Pain: A Systematic Review and Meta-Analysis
- Open Access
- 8 June 2024
- Published by Springer Nature in Current Pain and Headache Reports
- Vol. 28 (8) , 825-833
The Role of Platelet Rich Plasma in Vertebrogenic and Discogenic Pain: A Systematic Review and Meta-Analysis
Purpose of Review: The present investigation evaluates clinical uses and roles of platelet rich plasma in the management of vetrebrogenic and discogenic mediated pain states. Recent Findings: Back pain is a common and significant condition that affects millions of people around the world. The cause of back pain is often complex and multifactorial, with discogenic and vertebrogenic pain being two subtypes of back pain. Currently, there are numerous methods and modalities in which back pain is managed and treated such as physical therapy, electrical nerve stimulation, pharmacotherapies, and platelet-rich plasma. To conduct this systematic review, the authors used the keywords “platelet-rich plasma”, “vertebrogenic pain”, and “discogenic pain”, on PubMed, EuroPMC, Who ICTRP, and clinicaltrials.gov to better elucidate the role of this treatment method for combating vertebrogenic and discogenic back pain. In recent decades, there has been a rise in popularity of the use of platelet-rich plasma for the treatment of numerous musculoskeletal conditions. Related to high concentration of platelets, growth factors, cytokines, and chemokines, platelet-rich plasma is effective in reducing pain related symptoms and in the treatment of back pain. Summary: Platelet-rich plasma use has evolved and gained popularity for pain related conditions, including vertebrogenic and discogenic back pain. Additional well-designed studies are warranted in the future to better determine best practice strategies to provide future clinicians with a solid foundation of evidence to make advancements with regenerative medical therapies such as platelet-rich plasma.
- 8 June 2024
- Published by Springer Nature in Current Pain and Headache Reports
- Vol. 28 (8) , 825-833
Open AccessThe Role of Platelet Rich Plasma in Vertebrogenic and Discogenic Pain: A Systematic Review and Meta-Analysis
Purpose of Review: The present investigation evaluates clinical uses and roles of platelet rich plasma in the management of vetrebrogenic and discogenic mediated pain states. Recent Findings: Back pain is a common and significant condition that affects millions of people around the world. The cause of back pain is often complex and multifactorial, with discogenic and vertebrogenic pain being two subtypes of back pain. Currently, there are numerous methods and modalities in which back pain is managed and treated such as physical therapy, electrical nerve stimulation, pharmacotherapies, and platelet-rich plasma. To conduct this systematic review, the authors used the keywords “platelet-rich plasma”, “vertebrogenic pain”, and “discogenic pain”, on PubMed, EuroPMC, Who ICTRP, and clinicaltrials.gov to better elucidate the role of this treatment method for combating vertebrogenic and discogenic back pain. In recent decades, there has been a rise in popularity of the use of platelet-rich plasma for the treatment of numerous musculoskeletal conditions. Related to high concentration of platelets, growth factors, cytokines, and chemokines, platelet-rich plasma is effective in reducing pain related symptoms and in the treatment of back pain. Summary: Platelet-rich plasma use has evolved and gained popularity for pain related conditions, including vertebrogenic and discogenic back pain. Additional well-designed studies are warranted in the future to better determine best practice strategies to provide future clinicians with a solid foundation of evidence to make advancements with regenerative medical therapies such as platelet-rich plasma.